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1. Introduction
Oxidative stress is a large increase reduction potential in cell or a decrease in reducing ca‐
pacity of the cellular redox couples such as glutation. Effects of oxidative stress depend on
the magnitude of these changes, if the cell is able to overcome small perturbations and re‐
gain its original state. However, severe oxidative stress can cause cell death and even mod‐
erate oxidation can trigger apoptosis, whereas if it is too intense can cause necrosis.
A particularly destructive aspect of oxidative stress is the production of reactive oxygen spe‐
cies, which include free radicals and peroxides. Some of the less reactive species (superox‐
ide) can be converted by a redox reaction with transition metals or other compounds
quinines redox cycle, more aggressive radical species which can cause extensive damage cel‐
lular. Most of these species derived from oxygen are produced at a low level in normal aero‐
bic metabolism and the damage they cause to cells is constantly repaired. However, under
the severe levels of oxidative stress that causes necrotic damage produces ATP depletion
prevents cell death by apoptosis control.
The antioxidants are substances that may protect your cells against the effects of free radi‐
cals. Free radicals are molecules produced when your body breaks down food, or by envi‐
ronmental exposures like tobacco smoke and radiation. Free radicals can damage cells, and
may play a role in heart disease, cancer and other diseases.
Antioxidant substances include beta-carotene, lutein, lycopene, selenium, vitamin A; and vi‐
tamin C. Antioxidants are found in many foods. These include fruits and vegetables, nuts,
grains, and some meats, poultry and fish.
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Free radicals damage may lead to cancer. Antioxidants interact with and stabilize free radi‐
cals and may prevent some of the damage free radicals might otherwise cause.
Studies in cancer cells in vitro and in vivo animal’s models suggest that the use of free radi‐
cals decreases the growth of malignant cells. However, information from recent clinical tri‐
als is less clear. In recent years, large-scale, randomized clinical trials reached inconsistent
conclusions.
Clinical trials published in the 1990s reached differing conclusions about the effect of antiox‐
idants on cancer. The studies examined the effect of beta-carotene and other antioxidants on
cancer in different patient groups. However, beta-carotene appeared to have different effects
depending upon the patient population, therefore it is important to personalize treatment,
and we must take into account the variability to treatment and individualize or personalize
therapy. Studies made by Blot WJ et al., in 1993 for the treatment of cancer published in Chi‐
nese Cancer Prevention Study, investigated the effect of a combination of beta-carotene, vi‐
tamin E, and selenium on cancer in healthy Chinese men and women at high risk for gastric
cancer. The study showed a combination of beta-carotene, vitamin E, and selenium signifi‐
cantly reduced incidence of both gastric cancer and cancer overall.
A 1994 cancer prevention study entitled the Alpha-Tocopherol (vitamin E)/ Beta-Carotene
Cancer Prevention Study (ATBC) demonstrated that lung cancer rates of Finnish male smok‐
ers increased significantly with beta-carotene and were not affected by vitamin E. Epidemio‐
logic evidence indicates that diets high in carotenoid-rich fruits and vegetables, as well as
high serum levels of vitamin E (alpha-tocopherol) and beta carotene are associated with a
reduced risk of lung cancer. Another study made by Omenn GS in 1994, the Beta-Carotene
and Retinol (vitamin A). Efficacy Trial (CARET) also demonstrated a possible increase in
lung cancer associated with antioxidants.
The 1996 Physicians’ Health Study I (PHS) found no change in cancer rates associated with
beta-carotene and aspirin taken by U.S. male physicians.
The 1999 Women's Health Study (WHS) made by Lee IM, tested effects of vitamin E and be‐
ta-carotene in the prevention of cancer and cardiovascular disease among women age 45
years or older. Among apparently healthy women, there was no benefit or harm from beta-
carotene supplementation. Investigation of the effect of vitamin E is ongoing.
Three large-scale clinical trials continue to investigate the effect of antioxidants on cancer.
The Women’s Health Study (WHS) is currently evaluating the effect of vitamin E in the pri‐
mary prevention of cancer among U.S. female health professionals age 45 and older.
In 2006, the Selenium and Vitamin E Cancer Prevention Trial (SELECT) is taking place in the
United States, Puerto Rico, and Canada. SELECT is trying to find out if taking selenium
and/or vitamin E supplements can prevent prostate cancer in men age 50 or older. Also the
experimental and epidemiologic investigations suggest that alpha-tocopherol (the most
prevalent chemical form of vitamin E found in vegetable oils, seeds, grains, nuts, and other
foods) and beta-carotene (a plant pigment and major precursor of vitamin A found in many
yellow, orange, and dark-green, leafy vegetables and some fruit) might reduce the risk of
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cancer, particularly lung cancer. The initial findings of the Alpha-Tocopherol, Beta-Carotene
Cancer Prevention Study (ATBC Study) indicated, however, that lung cancer incidence was
increased among participants who received beta-carotene as a supplement. Similar results
were recently reported by the Beta-Carotene and Retinol Efficacy Trial (CARET), which test‐
ed a combination of beta-carotene and vitamin A.
The Physicians' Health Study II (PHS II) is a follow up to the earlier clinical trial by the same
name. The study is investigating the effects of vitamin E, C, and multivitamins on prostate
cancer and total cancer incidence. In another case the supplementation with alpha-tocopher‐
ol or beta-carotene does not prevent lung cancer in older men who smoke. Beta-Carotene
supplementation at pharmacologic levels may modestly increase lung cancer incidence in
cigarette smokers, and this effect may be associated with heavier smoking and higher alco‐
hol intake.
Antioxidants neutralize free radicals as the natural by-product of normal cell processes. Free
radicals are molecules with incomplete electron shells which make them more chemically re‐
active than those with complete electron shells. Exposure to various environmental factors,
including tobacco smoke and radiation, can also lead to free radical formation. In humans,
the most common form of free radicals is oxygen. When an oxygen molecule (O2) becomes
electrically charged or “radicalized” it tries to steal electrons from other molecules, causing
damage to the DNA and other molecules. Over time, such damage may become irreversible
and lead to disease including cancer. Antioxidants are often described as “mopping up” free
radicals, meaning they neutralize the electrical charge and prevent the free radical from tak‐
ing electrons from other molecules.
Because of the importance that involves using antioxidants as an alternative in the treatment
and prevention of chronic degenerative diseases is useful to express the potential in the use
and development of new drugs that include antioxidants.
Free radicals are highly reactive chemical species that possess an unpaired electron. Due to
it is reactivity, the radicals react readily with other molecules. When free radicals come into
contact with the molecules of the human body such as proteins, lipids, carbohydrates, DNA
nucleic acids, react with them. These reactions cause changes in the normal functions of
these primary metabolites, which cause severe damage that can cause diseases such as can‐
cer and degenerative diseases like Parkinson´s disease or Alzheimer´s disease and athero‐
sclerosis, coronary heart disease and diabetes [1-4].
When any of these afore mentioned diseases, the patient receive the treatment used to treat
the particular disease, however, prevention plays a big role. Oxidation in the body tissues
caused by free radicals can be prevented with a daily intake of foods that have antioxidants.
The implications of modern life cause changes in eating habits of people, these results in a
lack of antioxidants in the body to cope with free radicals that are in contact. The role of an‐
tioxidants is to react with free radicals and thus prevent, to react with the primary metabo‐
lites, thus acting as natural shields against diseases like cancer [5, 6].
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Figure 1. Antioxidants decrement oxidative processes. [Bruce Ames Ph.D., University of California Lecture U.C.T.V.
viewed on 08-14-2004].
2. Cancer
2.1. Breast cancer
Currently breast cancer is a disease of high incidence worldwide and causes millions of
deaths annually [7]. In the treatment of various cancers have been used drugs that originate
from natural products. To get to the application of the drug as a treatment, it requires years
of research. The use of treatment leads to the destruction of cancer cells and normal cells in
addition, there are numbers side effects resulting from the application of therapies. Preven‐
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tion of disease is certainly a great alternative to the aggressive use of medications commonly
used. The simplest method to prevent cancer and other diseases is undoubtedly add to the
diet foods that contain high concentrations of antioxidants, this treatment is easy to perform
and causes no adverse side effects. Other organisms containing large amounts of secondary
metabolites some of which can act as antioxidants and thereby help prevent cancer and pre‐
vent its development (Fruits, vegetables, plants).
Antioxidants can act in two ways:
Blocking cancer, in the initial stage protecting cells against oxidative species and enhancing
DNA repair.
Suppressing cancer by inhibiting the progressive stages after formation of pre-neoplastic
cells [8].
Studies are underway to help better understand the mechanism of action of antioxidants and test
its efficacy against cancer and other diseases. Several studies report that the addition to the diet of
foods containing antioxidants may increase the effectiveness of cancer treatment, and help
strengthen the body against the side effects associated with treatment [9-11]. The antioxidants
found in fruits and vegetables can mention vitamins C and E, carotenoids group and the group of
polyphenols. Polyphenols are a group of antioxidant flavonoids to which they belong. There are
several types of flavonoids and can be found in foods such as blackberries, blueberries, strawber‐
ries, plum, peach, apple, tomato, cherry, broccoli, onion, soya been, legumes like green gram, lu‐
pine peas, soy beans, white and horse gram, green leafy spices, citrus fruits, tea, red grapes,
chocolate, cocoa and red wine beverages [12].
The following briefly discuss some results of studies using antioxidants from fruits and veg‐
etables for the treatment of breast cancer.
Research conducted in Canada by Hakimuddin and colleagues [13] showed that the poly‐
phenols found in red wine have selective toxicity against MCF-7 cell type of breast cancer;
the authors indicate the importance of a diet that incorporates red wine and feeding grapes
to serve as a preventive strategy against cancer, which also can be combined with standard
therapies.
As mentioned above plums and peaches are fruits that contain phenolic compounds. In a
study to test the activity of phenolic species as cancer chemopreventive agents present in ex‐
tracts of plums and peaches, we found that peaches and plums contain a mixture of phenol‐
ic compounds with the ability to inhibit cell lines MCF-7 and MDA -MB435. A very
important point to consider is that phenolic acids were isolated chlorogenic and neo-chloro‐
genic which have great potential for use as chemopreventive agents exerting growth inhibi‐
tion of the cell line MDA-MB-435 and low toxicity to the normal cell line MCF-10A [14].
Another recent study [15], focused on the action of terpenes located in the skin of the olives
suggests that they may serve as natural potential protective against breast cancer. The triter‐
penes were isolated in significant quantities from the pulp of the olive oil and can act pro‐
phylactically and therapeutically.
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Currently the investigation for the treatment of breast cancer using apigenin, a flavonoid
found in celery. The study conducted at the University of Missouri (United States) [16] was
performed in mice that were implanted cell line BT-474, of rapid growth. Mice were also
treated with medroxyprogesterone acetate (MPA), which is used in postmenopausal wom‐
en. Another group of mice was used as a blank. The group of mice treated with MPA was
injected apigenin, found that cancerous tumors grew rapidly in mice that were treated with
apigenin. Moreover, in mice treated with apigenin was observed a decrease of the tumor
when compared with the group of mice used as a blank. Yet unknown mechanism of action
of apigenin chemical, however, although the study was conducted in mice, is very promis‐
ing for future treatment of breast cancer.
2.2. Prostate cancer
Prostate cancer is a very common type of cancer afflicting men; it is now easy detection by
prostate specific antigen test (PSA for its initials in English) [17]. Which are still unknown
factors that cause this type of cancer, the disease also takes years in some cases to express
symptoms, making it necessary for men to undergo regular medical examinations to detect
early. One form of treatment of prostate cancer is surgery, whereby the prostate is removed,
but this is a procedure which results in urinary incontinence and impotence, which in some
cases is permanent.
Prevention through diet prostate cancer has increased because it is recognized as a way to
combat this disease [18, 19]. Among the foods that are recommended for the prevention of
prostate cancer are generally fruits and vegetables due to its high content of antioxidants.
Fruits like pomegranate containing metabolites such as polyphenols and delphinidin uroliti‐
na A and B chloride, kaempferol, and punicic acid are considered biologically active against
prostate cancer [20, 21].
Other fruit that contains a variety of polyphenolic compounds is strawberry [22] has been
found that extracts of strawberry juice cell lines tested against prostate cancer proved effec‐
tive as antiproliferative agents, is also noteworthy to mention that were tested individually
some of the individual components of the extract (cyanidin-3-glucoside, pelargonidin, pelar‐
gonidin-3-glucoside, pelargonidin-3-rutinoside, kaempferol, quercetin, kaempferol-3-(6'-
coumaroyl) glucoside, 3,4,5 trihydroxyphenyl-acrylic acid-, glucose ester of (E)-p-coumaric
acid, and ellagic acid) which also showed efficacy individually [23]. These studies confirm
the effectiveness of the cutter to inhibit growth of cancer cells.
The apple is considered the quintessential fruit of health, its daily intake is associated with
low risk of chronic diseases and cancer, particularly prostate and colon [24-26]. The block
contains a variety of compounds polyphenolic that are responsible for their biological activi‐
ty among these compounds, studies were performed with quercetin which has proven effec‐
tive as an inhibitor in vitro cell growth of prostate cancer [23, 24]. Another study showed
that the antioxidant activity of apples is correlated [27] with the total concentration of phe‐
nolic compounds present in it clear that this concentration varies according to growing re‐
gion, and other growth period factors [28-30]. The tomato is another fruit with high
antioxidant capacity and owes its activity to lycopene, a carotenoid, which gives the charac‐
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teristic red color to the fruit [31, 32]. It has been reported that tomato consumption reduces
the occurrence of prostate cancer [33-35].
Another study used extracts of potato species Solanum jamesii to test their cytotoxic activity
toward antiproliferatva and prostate cancer cells and colon in vitro. The extracts were found
to inhibit proliferation of cancer cells PC-3 prostate as well as in colon cancer cells LNCaP.
Fractions were also tested extract containing anthocyanin and it showed the same activity as
the full extract [36].
2.3. Cervical cancer
It is a type of cancer that has one of the top female deaths worldwide [37]. Its main cause is
due to Human Papilloma Virus, which is a group of more than 150 types of viruses and is
transmitted by sexual contact [38]. To the treatment of cervical cancer, chemotherapy and ra‐
diation therapy is performed. As prevention against this type of cancer was recommended
not realize sexual contact with infected persons. Another form of prevention is the applica‐
tion of the vaccine that protects against types of HPV high risk of developing cancer. These
vaccines Gardasil ® and Cervarix ® were approved by the Federal Drug Administration
(FDA) of EU, but these vaccines are only for women, 9 to 26 years of age who are not infect‐
ed by the virus.
Another recommendation to prevent this cancer is to stimulate the immune system by eat‐
ing foods rich in antioxidants, because if the body is weakened, the virus is an opportunity
to attack and develop cancer [38]. Have also been performed in vitro studies to observe
foods as antioxidants influence on the growth of cervical cancer cells [39]. One study was
carried out with extracts of different types of berries and tested for anti-proliferative activity
on HeLa cells (cervical carcinoma). The results show that extracts from blueberry and pome‐
granate have little effect inhibiting the growth of HeLa cells. The most effective extracts with
increasing concentration were: strawberry extract, arctic bramble, lingonberry and cloudber‐
ry. It has also been reported [40] that glycoalkaloids present in commercial potatoes inhibit
the growth of different types of cancer cell lines, including HeLa cervical cancer cells.
In therapy of cancer selenium doses is 4000 µg in continuous infusion of 1000 µg/9 days, to‐
tal: 13 mg [41] (Forceville et al, 2007), i.v. bolus 1000 µg in 30 minutes for continuous infu‐
sion 1000 µg/d 14 d, total: 15 mg; i.v. bolus 2000 µg in 2 hours continuous infusion 1600
µg/d, 10 d, total 18 mg [42].
3. Diabetes
Diabetes is a metabolic disorder associated with defects in secretion and insulin action [43].
Type 1 diabetes also known as insulin dependent and type 2 diabetes called non-insulin de‐
pendent. Both conditions are associated with the formation of free radicals that cause oxida‐
tive stress and disease manifestation. Diabetes is associated with health problems such as
neuropathy, retinopathy, erectile dysfunction in men, kidney problems, healing and more
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[44, 45]. Because diabetes is a disease of oxidative stress, it is expected that the antioxidants
in fruits, vegetables and plants to help combat it.
Several studies report that a proper diet that includes antioxidants is important to reduce
the risk of diabetes. We have found that various antioxidants present in some foods and
plants as coumarins, some terpenes, flavonoids, lignans, phenylpropanoids, tannins and can
help people prevent disease and for helping diabetics [46, 47]. These substances exert their
activity by inhibiting the action of R-amylase enzyme. Amylase is an enzyme produced in
the pancreas and salivary glands; their function is to help the digestion of carbohydrates
[48]. Among the flavonoids that can inhibit R-amylase are the quercetin, myricetin, epigallo‐
catechin gallate, and cyanidin. Tannins, present in green and black teas, grapes, wine, rasp‐
berry, and strawberry, also seem to be good R-amylase inhibitors. Among fruits and
vegetables reported with inhibitory capacity toward the R-amylase in vitro are the red
grapes, strawberry, raspberry and, green pepper, broccoli, ginger, and carrot [49-54].
Thanks to these findings, it has been proposed the use of some natural metabolites present
in these fruits for the control of hyperglycemia following ingestion of food. The advantage
of these natural metabolites is that its use can avoid the side effects that occur when drugs
are used for this purpose [55, 56].
Consumption of foods rich in antioxidants can also prevent the complications of this dis‐
ease  has  recently  been shown that  biotin  is  a  vitamin which  is  part  of  the  B  vitamins,
which can be found in foods such as biotin find when we eat  certain vegetables:  cauli‐
flower,  peanut  butter,  mushrooms,  yeast,  potatoes,  mushrooms,  almonds,  walnuts,  soy‐
beans,  chickpeas,  grapes,  strawberries,  watermelon,  bananas,  wheat,  flour,  pasta,  bread,
oats,  rice,  liver,  yolk  egg,  kidney,  fish,  poultry  and  offal  in  general,  can  help  improve
metabolism and insulin sensitivity,  leading to decreased levels of blood sugar,  also sold
capsules  containing biotin [57,  58].
Resveratrol  is  a  polyphenol  present  in  red wine.  According to research Medical  Center,
University  of  Texas  Southwestern  in  the  U.S.  [60],  resveratrol  administered  directly  in‐
to  the  brain  of  diabetic  mice,  can  help  control  type  two  diabetes  by  improving  blood
sugar  levels.  What  makes the  resveratrol  is  to  activate  a  protein  called sirtuin which is
expressed in parts of the brain that govern the metabolism of glucose. Much remains to
be investigated but it is certainly likely that the intake of red wine under medical super‐
vision can help control  diabetes.
Also been studied antioxidants in plants and animals such as the following examples show.
A group of researchers at the University of Jaen in Spain isolated a compound called Cin‐
namtannin B-1 of the laurel, which has antioxidant properties that can eliminate free radi‐
cals that cause diseases such as diabetes. The university has signed an agreement with a
pharmaceutical for the distribution of this antioxidant [61].
Lipoic acid, also known as alpha lipoic acid or thioctic acid, is produced in small quantities
our bodies, it participates in the metabolism significantly. Can also be found in foods like
red meat, yeast and some vegetables such as spinach, broccoli.
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In this fatty acid properties are attributed as an antioxidant par excellence also can help re-
use of other antioxidants like vitamins C and E, glutathione and coenzyme Q10. Among the
many properties that are attributed to reduction of varicose veins, skin moisture, enhances
energy levels in the body, cancer protection among others.
Also attributed the reduction in blood glucose levels for type 2 diabetes and help combat the
discomforts caused by peripheral neuropathy, and therefore coupled with the effects men‐
tioned above, this antioxidant is ideal for diabetics [62-67].
Currently sold in different forms under different names, but the diabetic patient can take
doses of lipoic acid consuming identified through the diet. No indication that lipoic acid has
contraindications, although high doses can cause episodes of hypoglycemia [68].
4. Arteriosclerosis
Arteriosclerosis is the hardening of the arteries due to fat accumulation; this may lead to a
heart attack that can end life [69]. Atherosclerosis is a preventable disease with a balanced
diet and exercise. The diet should include variety of fruits and vegetables and be low in fat.
Antioxidants play an important role in preventing this disease, it is known that there is a
relationship between red wine consumption and the low incidence of cardiovascular dis‐
ease; this is due to the action of the antioxidants present in grapes. We recommend a daily
intake of 375 mL of red wine to increase levels of high density lipoprotein HDL proteins, ie
proteins responsible for transporting fat [70, 71]. Studies with another fruits can be deter‐
mining its effectiveness in the prevention of arteriosclerosis.
Another  fruit  that  has  been  investigated  for  its  antioxidant  and  cardiovascular  protec‐
tive  effects  are  blueberries.  Studies  realized in  Arkansas  State  University,  evaluated the
effect  on two groups of  mice for  twenty weeks.  One group was used as  a  target,  lead‐
ing a normal diet;  the other group was fed a blueberry base [72],  found that mice with
arterial  lesions,  a  significant  percentage decreased injuries,  compared with the group of
mice  that  did  not  eat  blueberries.  The  researchers  suggest  incorporating  blueberries  to
the  diet  to  improve  cardiovascular  health  and  recommended  as  the  ideal  fruit  for  the
treatment  of  hypercholesterolemia.
It is known that fruits such as cranberries have high antioxidant levels and tested their effec‐
tiveness in promoting cardiovascular health [73-75]. This study was supplemented to a
group of men for two weeks with cranberry juice. Over time he found an increase in plasma
antioxidant capacity and a decrease in LDL (low density lipoprotein) in addition to an in‐
crease in HDL in obese men. Work is to show whether supplementation based cranberry
juice may have the same antioxidant capacity and the same protective benefit as red wine, if
so would avoid alcohol.
In another study conducted at the University of Buffalo studied the effect of resveratrol as
an antioxidant and its possible use in treating atherosclerosis. In this investigation were not
used fruits or vegetables, but was used an extract of the plant. The extract containing resver‐
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atrol was administered at doses of 40 mg daily to a group of 10 people, another group of 10
people also served as a target. During the six weeks of the study, blood tests were per‐
formed on the results; researchers concluded that Polygonum cuspidatum extract has a ther‐
apeutic effect against oxidative stress. These results show that resveratrol, as already
mentioned above, are effective to counteract the effect of free radicals, and in the case of ar‐
teriosclerosis, can also help prevent it [76].
5. Obesity and metabolic syndrome
The metabolic syndrome has been identified as a target for dietary therapies to reduce risk
of cardiovascular disease; however, the role of diet in the etiology of the metabolic syn‐
drome is poorly understood. The metabolic syndrome consists of a constellation of factors
that increase the risk of cardiovascular disease and type 2 diabetes. The etiology of this syn‐
drome is largely unknown but presumably represents a complex interaction between genet‐
ic, metabolic, and environmental factors including diet [77-79]. The studies endothelial
function by assessing the vascular responses to L-arginine, the natural precursor of nitric ox‐
ide it´s characterized for the low-grade inflammatory state of patients with the metabolic
syndrome by measuring circulating levels of high-sensitivity C-reactive protein (hs-CRP) as
well as of interleukins 6 (IL-6), 7 (IL-7), and 18 (IL-18). These proinflammatory ILs have been
prospectively associated with thrombotic cardiovascular events [80, 81] or have been sug‐
gested to be involved in plaque destabilization [82]. The diet designed to increase consump‐
tion of foods rich in phytochemicals, antioxidants, α-linolenic acid, and fiber prevent
Metabolic Syndrome.
The diet rich in whole grains, fruits, vegetables, legumes, walnuts, and olive oil might be ef‐
fective in reducing both the prevalence of the metabolic syndrome and its associated cardio‐
vascular risk. One of the mechanisms responsible for the cardioprotective effect of such a
diet may be through reduction of the low-grade inflammatory state associated with the met‐
abolic syndrome. Although weight reduction remains a cornerstone of therapy for the meta‐
bolic syndrome, from a public health perspective adoption of a diet rich in phytochemicals,
antioxidants, α-linolenic acid, and fiber may provide further benefit on cardiovascular risk,
especially in patients who do not lose weight.
If antioxidants play a protective role in the pathophysiology of diabetes and cardiovascular
disease, understanding the physiological status of antioxidant concentrations among people
at high risk for developing these conditions, such as people with the metabolic syndrome, is
of interest. However, little is known about this topic. Because the prevalence of obesity,
which is associated with decreased concentrations of antioxidants [83], is high among peo‐
ple with the metabolic syndrome, they are probably more likely to have low antioxidant
concentrations. Consequently, our purpose was to examine whether concentrations of sever‐
al antioxidants are lower among those with than those without the metabolic syndrome.
For example a retinol from the liver, the main storage site for retinol is transported to pe‐
ripheral tissues by retinol binding protein. Retinol may be released as a retinyl ester; howev‐
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er, when the ability of the liver to store retinol is exceeded or when liver function is
impaired [84]. Thus, the higher retinyl ester concentrations among those who did not have
the metabolic syndrome may indicate that they consumed larger amounts of vitamin A com‐
pared with people who have this syndrome. Our findings may have implications for people
with the metabolic syndrome, health care professionals who care for them and researchers
who study the metabolic syndrome. People with the metabolic syndrome are at increased
risk for diabetes and cardiovascular disease, and a role for oxidative stress in the patho‐
physiology of these conditions has been postulated. Free radical species is one of the princi‐
pal mechanisms of action of antioxidants, other mechanisms that affect the pathophysiology
of diabetes and cardiovascular disease may be operating as well [83]. The effects of vitamins
C and E have received a great deal of interest. Through effects on oxidation of LDL choles‐
terol concentration, leukocyte adhesion, and endothelial function, vitamins C and E may
slow atherosclerosis [86, 87].
6. Liver cirrhosis
Currently the evidence supports the role of nutritional deficiency in Alcoholic Liver Disease
(ALD) [88–95]. Lieber and colleagues show that progressive ALD proceeds despite adequate
nutrition [96, 97]. The latter hypothesis was based primarily on the observation that baboons
fed a nutritionally adequate liquid diet containing ethanol at 50% calories developed nearly
the whole spectrum of ALD including cirrhosis. Studies demonstrated profound effects on
ethanol-induced liver injury by intake of nutrients such as polyunsaturated fat and iron in
quantities that were never thought to be important. The concept of ‘sensitization’ and ‘pri‐
ming’ is currently considered fundamental to our pursuit for elucidation of pathogenetic
mechanisms of ALD. The sensitization is a conditioning that makes the target cells, hepato‐
cytes, more vulnerable to harmful effects triggered by ethanol and priming as the effect that
promotes specific injurious mechanisms. The sensitizing and priming are rendered by the
complex interactions of primary mechanistic factors and secondary risk factors. For exam‐
ple, intake of polyunsaturated fat in ethanol-fed rats, but not in pair-fed controls, results in a
synergistic priming effect on induction of cytochrome P4502. E1 (CYP2E1) with consequent
oxidative injury to the liver [98]. Conversely, saturated fat prevents this priming effect and
abrogates depletion of a mitochondrial pool of glutathione (GSH) [99], one of the most cru‐
cial sensitization effects of ethanol on hepatocytes [100]. Iron is another example. Whereas a
slight increase in hepatic iron content by dietary iron supplementation is harmless in control
rats, it exacerbates alcoholic liver injury via accentuation of oxidative stress [101]. Further,
increased iron storage in hepatic macrophages is a potential priming mechanism fore‐
nhanced expression of tumor necrosis factor a (TNF-a) in experimental ALD [102] Besides
nutritional factors, female gender, age, concomitant intake of other drugs that can induce
CYP2E1, hepatitis virus infection, and genetic predisposition are all considered risk factors.
Even among the primary mechanistic factors that include acetaldehyde, oxidative stress, im‐
mune response, hypoxia, and membrane alterations, there are cross-interactive relationships
to render sensitization or priming effects. For instance, acetaldehyde, a potent toxic metabo‐
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lite of ethanol, induces liver injury via its covalent binding to structural or functional pro‐
teins of the cells [103] while promoting oxidative stress via consumption of GSH. In turn,
deleterious effects of acetaldehyde-protein adduct formation may be accentuated by oxida‐
tive stress since malondialdehyde, a lipid peroxidation end product, can increase the bind‐
ing affinity of acetaldehyde by 13-fold [104]. The resulting novel hybrid adducts are highly
immunogenic and may incite immune response mediated liver injury [105, 106]. Although
cellular immune response and inflammation are regarded as independent mechanisms of
ALD, they can also lead to oxidative stress via the release of reactive oxygen species (ROS)
by NADPH oxidase or action of TNF-a at the electron transport chain in target cells. The
multifactorial nature and complex interaction among primary mechanistic factors and be‐
tween primary and secondary factors appear to be the basis for the heterogeneous response
that alcoholics exhibit for ALD. Elucidation of the sensitization and priming mechanisms in‐
volving cross-interactions of these factors should allow us to gain insight into the most fun‐
damental question, which is why only a small fraction of alcoholics develop advanced ALD.
The experimental models to use for control deletion and addition analyses in order to identi‐
fy what primary and secondary factors are required for the expression of a particular aspect
or whole spectrum of experimental ALD. It is need experts in various disciplines need to
work together to provide cutting-edge science for elucidating the precise nature and mecha‐
nisms that underlie interactions.
Antioxidants represent a potential group of therapeutic agents for ALD. They likely provide
beneficial effects on hepatocytes via desensitization against oxidant stress while inhibiting
priming mechanisms for expression of proinflammatory and cytotoxic mediators via sup‐
pression of NF-kB [107, 108]. Potential approaches may include cell type-specific targeting of
antioxidant therapy and development of modalities for more specific and selective regula‐
tion of NF-kB-mediated signaling.
The development of cirrhosis is usually associated with oxidative stress and lipid peroxida‐
tion (LPO). Studies in models of cirrhosis to use carbon tetrachloride (CCl4) inhalation in the
rat show several similarities with human cirrhosis. The metabolism of CCl4 into trichloro‐
methyl (CCl3•) and peroxy trichloromethyl (•OOCCl3) free radicals has been reported to
cause hepatotoxic effects, like fibrosis, steatosis, necrosis, and hepatocarcinoma [109, 111].
Some compounds that have been studied as possible protectors against liver cirrhosis are
known for their anti-inflammatory and antioxidant properties. Plants contain numerous pol‐
yphenols, which have been shown to reduce inflammation and thereby to increase resist‐
ance to disease [112]. Quercetin (Q), a polyphenolic flavonoid compound present in large
amounts in vegetables, fruits, and tea, exhibits its therapeutic potential against many diseas‐
es, including hepatoprotection and the inhibition of liver fibrosis [113–114]. It contains a
number of phenolic hydroxyl groups, which have strong antioxidant activity [116, 117]. The
average intake varies between countries but is approximately 23 mg/day [118].
By increasing the endogenous antioxidant defenses, flavonoids can modulate the redox state
of organisms. The major endogenous antioxidant systems include superoxide dismutase
(SOD), catalase (CAT), glutathione reductase (GR), and glutathione peroxidase (GPx), which
is essential for the detoxification of lipid peroxides [119-121].
Oxidative Stress and Chronic Degenerative Diseases - A Role for Antioxidants368
7. Hypertension
Excessive reactive oxygen species (ROS) have emerged as a central common pathway by
which disparate influences may induce and exacerbate hypertension. Potential sources of
excessive ROS in hypertension include nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase, mitochondria, xanthine oxidase, endothelium-derived NO synthase, cy‐
clooxygenase 1 and 2, cytochrome P450 epoxygenase, and transition metals. While a signifi‐
cant body of epidemiological and clinical data suggests that antioxidant-rich diets reduce
blood pressure and cardiovascular risk, randomized trials and population studies using nat‐
ural antioxidants have yielded disappointing results. The reasons behind this lack of efficacy
are not completely clear, but likely include a combination of [122] ineffective dosing regi‐
mens, [123] the potential pro-oxidant capacity of some of these agents, [124] selection of sub‐
jects less likely to benefit from antioxidant therapy (too healthy or too sick), and inefficiency
of nonspecific quenching of prevalent ROS versus prevention of excessive ROS production.
Antioxidants as vitamins A, C and E, L-arginine, flavonoids, and mitochondria-targeted
agents (Coenzyme Q10, acetyl-L-carnitine, and alpha-lipoic acid) can be use to treatment hy‐
pertension. Currently exist incomplete knowledge of the mechanisms of action of these
agents, lack of target specificity, and potential interindividual differences in therapeutic effi‐
cacy preclude us from recommending any specific natural antioxidant for antihypertensive
therapy at this time.
Reactive oxygen species (ROS) are generated by multiple cellular sources, including
NADPH oxidase, mitochondria, xanthine oxidase, uncoupled endothelium-derived NO syn‐
thase, cycloxygenase, and lipoxygenase. The dominant initial ROS species produced by
these sources is superoxide (O2−). Superoxide is short-lived molecule that can subsequently
undergo enzymatic dismutation to hydrogen peroxide. Superoxide can oxidize proteins and
lipids, or react with endothelium-derived nitric oxide (NO) to create the reactive nitrogen
species peroxynitrite. Peroxynitrite and other reactive nitrogen species can subsequently ox‐
idize proteins, lipids, and critical enzymatic cofactors that may further increase oxidative
stress [125]. Hydrogen peroxide produced by enzymatic dismutation of O2− can be further
convert to highly reactive hydroxyl radical (via Fenton chemistry) that can cause DNA dam‐
age. The balance between superoxide production and consumption likely keeps the concen‐
tration of O2− in the picomolar range and hydrogen peroxide in the nanomolar range [126].
These homeostatic levels of reactive oxygen species appear to be important in normal cellu‐
lar signaling [127-132] and normal reactions to stressors [133, 134].
Randomized trials employing non-pharmacological dietary interventions emphasizing
fruits, vegetables, whole grains, and nuts have shown impressive blood pressure lowering
results in both hypertensive and normotensive subjects [135, 136]. Similar interventions
demonstrated to reduce cardiovascular morbidity and mortality continue to maintain inter‐
est in the potential of isolating specific compounds enriched in these diets that may be re‐
sponsible for the overall dietary benefits [137].
The dietary components in these studies are high in compounds known to have antioxidant
properties leading many to ascribe the benefits of these diets to their increased content of
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natural antioxidants. However, prior randomized trials and population studies in healthy
populations and patients at high risk for cardiovascular events that have employed combi‐
nations of some of these natural antioxidants as dietary supplements have, for the most part,
shown disappointing results [138-145]. The reasons behind these disappointing results are
not completely clear, but likely include a combination of 1) ineffective dosing and dosing
regimens 2) the potential pro-oxidant capacity and other potentially deleterious effects of
these some of these compounds under certain conditions [146-148], 3) selection of subjects
less likely to benefit from antioxidant therapy (too healthy or too sick). Populations at inter‐
mediate cardiovascular risk may be better suitable to see effects of antioxidants in shorter
term studies [149], 4) inefficiency of non-specific quenching of prevalent ROS versus preven‐
tion of excessive ROS production [150, 151].
When considering antioxidant therapy for hypertension, lessons from prior disappointing
attempts to reduce blood pressure and cardiovascular risk with antioxidant therapy should
be considered. The profile of an ideal agent is outlined in The importance of patient selec‐
tion is being increasingly recognized in light of emerging data suggesting that antioxidant
supplementation in healthy subjects may blunt the protective benefits of aerobic exercise
training, suggesting ROS generation can be beneficial under certain circumstances.
Antioxidants neutralize the oxidative processes and modify levels in plasma
↑ Lipid peroxidation ↑ MDA (TBAR), F2-isoprostane
↑ NO synthesis ↑ Nitrite, nitrate, nitrotyrosine
↓ Circulating antioxidants ↓ Uric acid, protein SH groups, Bilirubin
(unconjugated)
↓ Ascorbic acid, α-tocopherol, β-carotene,
lycopene
↓ Antioxidant enzymes (GSHPx)
↓ Selenium, zinc
↓ GSH
Xanthine oxidase activation ↑ Plasma xanthine oxidase
Table 1. Antioxidants neutralize the oxidative processes and modify levels in plasma. [150]
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7.1. Antioxidant vitamins
7.1.1. Vitamin A precursors and derivatives
Vitamin A precursors and derivatives are retinoids that consist of a beta-ionone ring attach‐
ed to an isoprenoid carbon chain. Foods high in vitamin A include liver, sweet potato, car‐
rot, pumpkin, and broccoli leaf. Initial interest in vitamin A-related compounds focused
primarily on beta-carotene, given initial promising epidemiological data with respect to its
cardioprotective effects and some correlation with higher plasma levels to lower blood pres‐
sure in men. However, concerns about beta-carotene’s pro-oxidative potential came to light
with a report suggesting adverse mitochondrial effects of beta-carotene cleavage products.
Further, adverse mortality data with respect to beta-carotene has limited interest in this
compound as an effective antihypertensive agent.
Recently, interest in vitamin A derivatives has turned to lycopene, itself a potent antioxidant
[152], found concentrated in tomatoes. One small study has shown a reduction in blood
pressure with a tomato-extract based intervention (containing a combination of potential an‐
ti-oxidant compounds including lycopene) in patients with stage I hypertension, [153] al‐
though second study showed no effect in pre-hypertensive patients [154].
7.1.2. Ascorbic acid (Vitamin C)
L-ascorbic acid is a six-carbon lactone and, for humans, is an essential nutrient. In Western
diets, commonly consumed foods that contain high levels of ascorbic acid include broccoli,
lemons, limes, oranges, and strawberries. Toxicity potential of this compound is low, al‐
though an increased risk of oxalate renal calculi may exist at higher doses (exceeding 2
grams/day).
The initial purported mechanisms for the potential benefits of ascorbate supplementation
were centered on quenching of single-electron free radicals. Subsequent research has dem‐
onstrated that the plasma concentrations of ascorbate required for this mechanism to be
physiologically relevant are not attainable by oral supplementation [155]. However, vitamin
C can concentrate in local tissues to levels an order of magnitude higher than that of plasma.
At this ascorbate may to effectively compete for superoxide and reduce thiols [156]. Recent
data also suggest potential suppressive effects of ascorbate on NADPH oxidase activity [157,
158]. Ascorbate appears to have limited pro-oxidant ability. [159].
Ascorbate’s anti-hypertensive efficacy has been evaluated in multiple small studies
[160-163] but not all, show modest reductions in blood pressure in both normotensive and
hypertensive populations. These data also suggest that supplementation has limited effect
on systemic antioxidant markers and little additional blood pressure benefits are seen be‐
yond the 500 mg daily dose. Large scale randomized trial data specific to ascorbate supple‐
mentation and its effects on hypertension are currently lacking. Data from Heart Protection
Study (HPS) suggest no significant mortality from supplementation with 250mg/day of as‐
corbate supplementation. However, the relatively low dose of ascorbate, use of combination
therapy, and high-risk patient population studied in HPS leave unanswered the key ques‐
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tions of appropriate dosing and target. In the inflammatory processes follow next scheme in
the therapy antioxidant [164].
Figure 2. Restored normal endothelial function.
7.1.3. α-Tocopherol (Vitamin E)
Vitamin E is a generic term for a group of compounds classified as tocopherols and tocotrie‐
nols [165]. While there are four isomers in each class of Vitamin E compounds, the over‐
whelming majority of the active form is α-tocopherol. [166, 167]. Dietary sources high in
vitamin E include avocados, asparagus, vegetable oils, nuts, and leafy green vegetables.
Vitamin E is a potent antioxidant that inhibits LDL and membrane phospholipid oxidation.
Interestingly, inflammatory cells and neurons have binding proteins for α-tocopherol, the
actions of which may include inhibition of NADPH oxidase, lipoxygenase, and cyclo-oxy‐
genase, actions which may lower oxidative stress [168]. However, studies demonstrating vi‐
tamin E’s pro-oxidant capacity under certain cellular conditions suggest that local condition
may influence the vitamin E’s redox activity [169]. Initial excitement for vitamin E supple‐
mentation was based on the reduction of cardiovascular events seen in the CHAOS study.
However, follow-up studies have been largely disappointing [170-171]. While one small
study that used vitamin E in combination with zinc, vitamin C, and beta-carotene showed a
modest, significant reduction in blood pressure over 8 weeks of therapy, other small studies,
show either no effect from vitamin E supplementation. Further, the more definitive HOPE
Oxidative Stress and Chronic Degenerative Diseases - A Role for Antioxidants372
trial, failed to show blood pressure or mortality benefit for patients at high risk for cardio‐
vascular disease [172]. Vitamin E inhibits free radicals reactions.
 
Figure 3. Antioxidants function in the organism.
7.1.4. L-Arginine
L-arginine is an amino acid and the main substrate for the production of NO from eNOS in a
reaction that is dependent on tetrahydrobiopterin [173]. Potential dietary sources include
milk products, beef, wheat germ, nuts, and soybeans. Reduced levels of tetrahydrobiopterin
leads to uncoupling of reduced NADPH oxidation and NO synthesis, with oxygen as termi‐
nal electron acceptor instead of L-arginine, resulting in the generation of superoxide by
eNOS [174-176]. Low cellular levels of L-arginine have been demonstrated in human hyper‐
tension. While L-arginine deficiency itself does not appear to lead to uncoupling of eNOS,
[177] low levels of L-arginine may lead to reduced levels of bioavailable NO which could
contribute to hypertension. Thus, L-arginine supplementation could theoretically reduce
blood pressure by allowing for restoration of normal NO bioavailability, perhaps overcom‐
ing overall L-arginine deficiency as well as more successfully competing fo the eNOS active
site with circulating asymmetric dimet hylarginine, a circulating competitor of L-arginine
that may be increased in the setting of hypertension.
This concept is supported by studies demonstrating the anti-hypertensive effect of L-argi‐
nine supplementation in salt-sensitive rats, healthy human subjects, hypertensive diabetics,
patients with chronic kidney disease, and diabetic patients in combination with N-acetylcys‐
teine, a precursor of glutathione [178] L-arginine’s anti-hypertensive response may be medi‐
ated in part by its suppressive effects on angiotensin II and endothelin-1, and its
potentiating effects on insulin.
However, recent concerns about potential deleterious increases in homocysteine in the set‐
ting of L-arginine supplementation have been raised. The majority of L-arginine is process‐
ed into creatine, which leads increased homocysteine levels. Homocysteine can increase
oxidative stress. A recent study confirms that this mechanism is relevant to L-arginine me‐
tabolism in humans [179] suggesting a potential mechanism for neutralizing the eNOS-relat‐
ed anti-oxidant effects of L-arginine.
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7.1.5. Flavonoids
Flavonoids are polyphenolic compounds commonly found in concentrated amounts in multi‐
ple fruits, vegetables, and beverages, including apples, berries, grapes, onions, pomegranate,
red wine, tea, cocoa, and dark chocolate. The exact structure and composition of the flavonoid
compounds varies between food sources, and flavonoid content can be altered based on the
manner of food preparation [180]. Interest in flavonoids as antioxidants therapy for cardiovas‐
cular disease originates from epidemiological data suggesting improved cardiovascular out‐
comes in individuals with high intake of food and beverages with high flavonoid content as
well as cellular work suggesting a strong anti-oxidant effect of these compounds [181]. Howev‐
er, the limited oral bioavailability of flavonoids suggests cells signaling mechanism, rather than
free radical quenching activity, is more likely to be root of sustained cardiovascular benefits
from flavonoids [182, 183]. This concept is consistent with studies demondtrating that flavo‐
noids can inhibit NADPH oxidase through ACE inhibition, increase eNOS-specific NO pro‐
duction through the estrogen receptor, and alter COX-2 expression [184]. Studies investigating
the anti-hypertensive effects of flavonoids are inconclusive. While multiple small studies of
short duration of dark chocolate therapy have demonstrated blood pressure lowering effects in
hypertensives [185], studies in normotensive and pre-hypertensive individuals have demon‐
strated no benefit [186], further tea intake may, at least temporarily, increase blood pressure
certain populations [187, 188]. The specific flavonoids and combination of flavonoids that exert
the largest beneficial effects remain unknown. The follow table indicates a function of antioxi‐
dants in therapy.
Selenium Septic ICU patients; major burns in
combination with Cu and Zn; trauma
patients
Ceiling "/>750 µg/day?
Zinc Pneumonia in children: clinical course
significantly shortened
Immune depression if doses"/>50
mg7day are provided
Cu-Se-Zn Burns: trials showing reduction of
infectious complication (pneumonia)
and improved wound healing
Doses were calculated to compensate
for the exudative losses
Vitamin E (α-tocoferol) SIRS enteral supplementation Convincing animal data
Vitamin C (ascorbic acid) Burns, megadose during the first 24 h
after injury; trauma, combined with
vitamin E
Possible an endothelial mechanism
(189)
Table 2. Antioxidants more indicated in treatments degeneratives chronics.
8. Conclusions
The antioxidants present in food playing an important role in preventing chronic diseases. A
balanced diet can prevent diseases associated with oxidative stress and help keep the body
in top condition.
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